InvestorsHub Logo
icon url

Andy2018

08/08/20 11:07 PM

#3230 RE: kalkid1 #3227

It seems they have contacted NeuroRX per that website.

The company supplying RLF-100 offered a “One Time Compassionate Use” for an end of life scenario as long as forms were filled out from the FDA, NIH and Dr. Prater. Karen got the forms for Pinckard and approval from the Director of the Pharmacy at Banner, Ambrosia Johnson, who said, “you get me that drug and we’re on board.”

However, Dr. Prater insists that Gabriella doesn’t qualify and, and according to Karen, he wants to know what the side effects of the drug are. “Who the hell cares,” said Karen, “This woman is dying and if there’s an opportunity for this to give her a chance, fill out the forms.”